AGP Executive Report
Last update: 3 hours agoPublic Health & Policy: Australian experts warn a US push to cut childhood vaccines isn’t science-based and could ripple into lower uptake abroad. Clinical Microbiology: UT Health San Antonio’s fungus lab is on the front line of drug-resistant infections, identifying new species and guiding treatment when options run out. Obesity Science: A Yale study suggests semaglutide’s weight-loss effects may rely on hunger-linked brain cells, reshaping how future obesity drugs could be designed. AI Drug Discovery: A reality check on AI in pharma finds lab wins but still elusive clinical proof, with data quality and decision-making benchmarks lagging. Space Medicine: A teen finalist built a low-cost device to test red-light wound healing under simulated microgravity, boosting regeneration in flatworms. Climate & Health: A virologist/public-health lens highlights how heat and climate shifts worsen health risks, while Europe’s heat waves show how a warming world intensifies extremes. Science Tools for Real Life: iNaturalist keeps turning everyday sightings into biodiversity data, blending citizen science with fun. Tech & Society: A new debate on “black-box” tools and AI autonomy underscores growing concerns about control and accountability.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.
Perspectify News
